{"id":7818,"date":"2015-02-05T17:24:50","date_gmt":"2015-02-05T16:24:50","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=7818"},"modified":"2015-02-06T20:38:13","modified_gmt":"2015-02-06T19:38:13","slug":"pfizer-compra-hospira-operazione-da-17-miliardi","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/pfizer-compra-hospira-operazione-da-17-miliardi\/","title":{"rendered":"Pfizer buys Hospira, 17 billion deal"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft\" alt=\"\" src=\"https:\/\/encrypted-tbn0.gstatic.com\/images?q=tbn:ANd9GcSgRdmGqmBw7I8aSLMIZJGtm00fyPDaRFntuKPkDwKtolkrUpRx9Q\" width=\"337\" height=\"149\" \/>(Teleborsa) \u2013 News in the pharmaceutical sector. The American\u00a0<a href=\"http:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer_to_acquire_hospira\" target=\"_blank\" rel=\"noopener\">Pfizer has acquired Hospira<\/a>\u00a0, putting up $90 for each share of the pharmaceutical company specializing in injectable drugs, with a premium of 39% on the stock&#039;s close yesterday.<\/p>\n<p>The deal has an enterprise value of approximately $17 billion.<\/p>\n<p>The deal will be financed through a combination of cash and debt: $15.2 billion in cash plus debt assumption.<\/p>\n<p>The market applauds the operation causing the Pfizer stock to jump by almost 3 percentage points. Flywheel of the 34% the Hopsira shares.<\/p>\n<p><a href=\"http:\/\/borse.quifinanza.it\/News\/2015\/02\/05\/pfizer-compra-hospira-operazione-da-17-miliardi-219.html\" target=\"_blank\" rel=\"noopener\">Posted on\u00a0<time id=\"ctl00_phContents_tmDateTime\" datetime=\"2015-02-05\">05\/02\/15<\/time>\u00a0in Finance | Source: Teleborsa | Here Finance<\/a><\/p>\n<p><em>Note: <a href=\"http:\/\/www.pfizer.com\/system\/files\/presentation\/Hospira%20Announcement%2002%2005%2015%20FINAL.pdf\" target=\"_blank\" rel=\"noopener\">Pfizer + Hospira synergies<\/a><\/em><\/p>\n<p>Hospira&#039;s CEO is\u00a0<strong><a href=\"http:\/\/www.bloomberg.com\/research\/stocks\/people\/person.asp?personId=249235&amp;ticker=HSP&amp;previousCapId=9681063&amp;previousTitle=HOSPIRA%20INC\" target=\"_blank\" rel=\"noopener\">F. Michael Ball<\/a><\/strong>, 58 years old. During the 2013 fiscal year, he received total compensation of\u00a0<strong>$ 9.892.283<\/strong>. Hospira has 17,000 employees (as of 12\/02\/2014)<\/p>\n<p>Pfizer&#039;s CEO is\u00a0<strong><a href=\"http:\/\/www.bloomberg.com\/research\/stocks\/people\/person.asp?personId=28845323&amp;ticker=PFE&amp;previousCapId=162270&amp;previousTitle=PFIZER%20INC\" target=\"_blank\" rel=\"noopener\">Ian C. Read<\/a><\/strong>, 60 years. During the 2013 fiscal year, he received a total compensation of\u00a0<strong>$ 18.947.747<\/strong>. In 2012, Pfizer had 113,700 employees.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft\" alt=\"Current Stock Chart for PFIZER INC (PFE)\" src=\"http:\/\/www.bloomberg.com\/apps\/chart?timeout=10&amp;h=225&amp;w=220&amp;type=gp_line2&amp;range=1y&amp;ticks=PFE:US&amp;cfg=ChartBuilderVol_bw.xml&amp;img=png\" width=\"220\" height=\"225\" \/>Pfizer Stock Exchange Valuation<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/media.mimesi.com\/cacheServer\/servlet\/CropServer?date=20150206&amp;idArticle=200128802&amp;authCookie=1598914219\" target=\"_blank\" rel=\"noopener\"><b>Pfizer is going on the offensive in general<\/b><\/a> (Les Echos)<\/p>","protected":false},"excerpt":{"rendered":"<p>(Teleborsa) &#8211; Novit\u00e0 nel settore farmaceutico. La statunitense\u00a0Pfizer\u00a0ha rilevato\u00a0Hospira\u00a0, mettendo sul piatto 90 dollari per ogni azione della societ\u00e0 farmaceutica specializzata in farmaci iniettabili, con un premio del 39% sulla chiusura del titolo ieri. Il deal ha un enterprise value di circa 17 miliardi di dollari. L&#8217;operazione verr\u00e0 finanziata attraverso una combinazione di cassa e &hellip;<\/p>","protected":false},"author":4,"featured_media":737,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[51,53,46],"class_list":["post-7818","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-compenso-top-manager","tag-fusioniacquisizioni","tag-pfizer"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/7818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=7818"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/7818\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/737"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=7818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=7818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=7818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}